How much should a pharma brand budget for GEO?
Most pharma GEO budgets pay for a visibility score. Here is what the budget should actually cover, how to size it, and how to tell whether it worked. There’s a budget sizer partway down if you’d rather start there.
Every brand team I talk to is asking some version of the same question. Patients and physicians are getting answers from ChatGPT, Google AI Overviews, Perplexity, and Gemini, so how much should we spend to show up there?
It’s a fair question, usually asked too early. Before you can put a number on a generative engine optimization budget, you need to know what you’re buying, and most of the GEO budgets I see are buying the wrong thing.
Short answer. A pharma GEO budget funds four things, in this order: an accuracy audit across the AI surfaces your audience uses, MLR-cleared content and schema fixes, standing monitoring for drift, and a connection to your existing analytics. The audit sizes the other three. Anyone who hands you a total before asking about your indications, your surfaces, and your MLR throughput is quoting a subscription, not a program.
The most common GEO budgeting mistake is buying a score
The easiest thing to buy in GEO right now is a dashboard: a citation rate, an AI share of voice, and a chart that goes up and to the right. For a consumer brand, that may be enough. If an AI engine recommends a competitor’s running shoe, you lose a sale.
Pharma is different. If an AI answer misstates an indication, leaves out a contraindication, or repeats last year’s dosing, you have a promotional-control problem on a channel you don’t own, and a visibility score won’t tell you about it. A brand can be cited often and described wrongly at the same time.
So the first budgeting rule is simple. Don’t fund visibility until you’ve funded accuracy.
What a pharma GEO budget should cover
A real GEO program for a regulated brand has four line items. If a proposal skips one, ask why.
| Line item | What it buys | One-time or standing | Where the cost usually hides |
|---|---|---|---|
| 1. Accuracy audit | What each AI surface says about your brand, and whether it’s on-label | One-time, then repeated after label events | Nowhere. This is the cheap part. |
| 2. Content and schema fixes | Changes to the pages and structured data the engines learn from | Project, paced by MLR | MLR review cycles. This is most of the real cost. |
| 3. Drift monitoring | Catching answers that change when your site didn’t | Standing, monthly | Someone has to read the answers, not just count them |
| 4. Measurement connection | AI referrals in GA4 next to your key actions | One-time setup, light upkeep | Tagging and reporting work that nobody scoped |
Two of these deserve a word. “AI search” isn’t one channel: Google AI Overviews, consumer ChatGPT, ChatGPT for Clinicians, Perplexity, Gemini, and Claude pull from different sources and answer differently, so the audit has to be run per surface, and an HCP specialty brand and a patient chronic brand shouldn’t audit the same way.
And line item 2 is where the money goes, even though it’s rarely in the proposal. Fixing what AI engines say about your brand means changing the pages they learn from, and every change goes through medical, legal, and regulatory review. If your MLR team can clear four pieces a month, your GEO program moves at four pieces a month, whatever the vendor promises.
How to size a GEO budget
Be skeptical of anyone who gives you a number before asking questions. The honest drivers are how many indications are in scope, which surfaces your audience actually uses, how often your label or core claims change, and how much MLR capacity you have. That last one sets the pace more than anything else.
A single-indication specialty brand with stable labeling needs a much smaller program than a multi-indication brand heading into a launch. The audit should size the rest of the budget, which is one more reason to fund it first.
Size your own program
Answer four questions about your brand. You’ll see how the line items split, how long the content work takes at your MLR team’s real pace, and which constraint is actually setting your budget. It won’t give you a price. It will tell you what shape the program should be before anyone quotes one.
- Accuracy audit
- Content and schema
- Drift monitoring
- Measurement
Effort estimates from PharmaForward’s program model, not a quote. They exclude media, your MLR reviewers’ own time, and any site build. The audit is what turns this into a number you can defend.
How to measure, benchmark, and report progress
A citation count going up is a start, not a measurement program. A GEO program you can defend to a brand lead tracks three layers, and the agency should be able to say on day one how each is captured, what the baseline is, and how often you’ll see it.
What the engines say. The audit, repeated on a schedule. For a fixed set of queries per indication and surface, record whether the brand appears, whether it’s cited, and whether the answer is on-label. Report share of accurate answers, which can move even while raw citations stay flat. Baseline it before any content ships.
What reaches your site. Referrers from ChatGPT, Perplexity, Gemini, and Copilot can be grouped into a custom channel in GA4. AI Overview clicks carry no distinct referrer and land in Google organic, so the proxy is Search Console impressions and clicks on the queries the audit tracks. Ask how the agency handles that gap, not whether it exists.
What it drives. AI referral sessions reported against the brand’s key actions: locator searches, rep requests, discussion guide downloads, support enrollments. If the brand assigns proxy values to those actions, apply the same values here so AI search sits on one scale with paid and organic.
| What | How often | Who reads it |
|---|---|---|
| Answer accuracy and citation status per surface | Monthly, plus within a week of any label event | Brand and regulatory |
| AI referral traffic and key actions in GA4 | Monthly, in the same report as organic and paid | Brand and digital |
| Full re-audit against baseline | Quarterly | Brand lead and whoever owns the budget |
| Drift alerts | As they happen | Whoever owns the response |
Insist on three things: the baseline is captured before work starts, the query set is fixed and documented so the score can’t be improved by changing what’s measured, and the reporting lives in the brand’s own analytics so the numbers survive a vendor change.
Where the money should come from
For most brands, GEO shouldn’t be new money. It overlaps heavily with SEO and paid search work you already fund, and the same pages, schema, and measurement serve all three. Move part of the search budget into GEO and measure it against the same outcomes.
Be careful about who’s grading the work. If the team that runs your media also reports on your AI visibility, ask whether anyone independent is checking the answers. It’s the same reason companies use outside auditors.
For one oncology brand, we took Google AI Overview citations from zero to 82 in 60 days. The number mattered because the answers citing the brand were on-label, and because that traffic showed up in the brand’s measurement next to the actions that counted.
Four questions to ask before you sign a GEO proposal
- Does it measure whether AI answers about my brand are accurate, or only whether my brand appears?
- Does the timeline reflect my MLR team’s real review capacity?
- Will AI search results show up in my analytics next to my key actions, or only in the vendor’s dashboard?
- How will you measure, benchmark, and report progress: what’s the baseline, what’s the fixed query set, how often do I see results, and what happens when an answer drifts?
If a proposal can’t answer all four, you’d be paying for a chart.
Frequently asked questions
- What is generative engine optimization (GEO)?
- GEO is the work of shaping how AI answer engines such as Google AI Overviews, ChatGPT, Perplexity, and Gemini describe and cite a brand. For pharma, that means making sure the pages and structured data those engines learn from are accurate, on-label, and current, and then verifying what the engines actually say.
- How much does GEO cost for a pharma brand?
- It depends on how many indications are in scope, which AI surfaces your audience uses, how often your label changes, and how fast your MLR team can review content. The audit should come first because it sizes everything else. Be wary of a fixed price quoted before those four questions are answered.
- How do you measure whether GEO is working?
- Three layers, and you need all of them. First, whether AI answers about the brand are accurate and cite the brand's own pages, scored against a fixed query set and a baseline captured before work began. Second, whether AI referral traffic shows up in GA4 as its own channel, with Search Console covering the AI Overview gap. Third, whether that traffic drives the actions the brand cares about, such as locator use, rep requests, and support sign-ups, valued the same way as every other channel.
- How often should a pharma brand report on GEO?
- Monthly for answer accuracy and AI referral performance, quarterly for a full re-audit against baseline, and within a week of any label change. Drift in a specific answer should be flagged as it happens, not saved for the monthly report.
Not sure where your brand stands in AI answers today? PharmaForward starts with a briefing, not a pitch deck. We’ll show you what the major AI engines say about your brand, where it’s accurate, and where it’s drifting. Then we can talk about what a budget should cover.
Book a briefing →More from Thinking: Your AI visibility report is measuring the wrong queries · You can rank #1 on Google and still be invisible in AI search